Logans Dental

The Best In Health

Pfizer Completes Acquisition of Arena Pharmaceuticals

6 min read
Pfizer Completes Acquisition of Arena Pharmaceuticals

Acquisition delivers new, differentiated, and probably finest-in-course method to deal with requires of a broader variety of individuals with immuno-inflammatory diseases

NEW YORK, March 11, 2022–(Company WIRE)–Pfizer Inc. (NYSE: PFE) declared right now the completion of its acquisition of Arena Prescribed drugs, a scientific phase corporation building impressive prospective therapies for the cure of various immuno-inflammatory health conditions.

Arena Prescribed drugs brings to Pfizer a portfolio of assorted and promising growth-stage therapeutic candidates in gastroenterology, dermatology, and cardiology, like etrasimod, an oral, selective sphingosine 1-phosphate (S1P) receptor modulator now in enhancement for a vary of immuno-inflammatory conditions together with ulcerative colitis, Crohn’s Illness, atopic dermatitis, eosinophilic esophagitis, and alopecia areata.

“We are enthusiastic to add the spectacular working experience and pipeline of Arena Prescription drugs to Pfizer’s Inflammation and Immunology therapeutic space, helping us additional our function of producing breakthroughs to change the life of individuals with immuno-inflammatory ailments,” reported Mike Gladstone, International President & Normal Manager, Pfizer Irritation and Immunology. “In specific, we’re hopeful that we can accelerate scientific progress of etrasimod effectively to have a positive affect on all those dwelling with these debilitating ailments.”

Arena has formerly indicated that it expected the success of the Period 3 ELEVATE-UC demo of etrasimod in ulcerative colitis during the initial quarter of 2022.

Arena’s pipeline also features two enhancement-stage cardiovascular belongings: temanogrel for microvascular obstruction and Raynaud’s phenomenon secondary to systemic sclerosis, and APD418 for acute coronary heart failure.

Added Transaction Specifics

Pfizer has completed its acquisition of all superb shares, options, and restricted inventory units of Arena for $100 for each share, in income, for a total fairness worth of about $6.7 billion. The acquisition was finished by way of a merger in accordance with Delaware regulation and, as a final result of the acquisition, Arena turned a wholly-owned subsidiary of Pfizer. In link with the acquisition, Arena’s shares of common inventory will be delisted from the Nasdaq World wide Find Market on or about March 11, 2022.

For supplemental qualifications on the acquisition, make sure you read through the announcement push launch right here.

About Pfizer Inflammation & Immunology
At Pfizer Swelling & Immunology, we attempt to supply breakthroughs that help flexibility from working day-to-day suffering for persons dwelling with autoimmune and serious inflammatory diseases, which can be debilitating, disfiguring and distressing, considerably affecting what they can do. With a emphasis on immuno-inflammatory situations in Rheumatology, Gastroenterology and Health care Dermatology, our existing portfolio of authorized medicines and investigational molecules spans various motion and shipping mechanisms, from topicals to modest molecules, biologics and biosimilars. The root lead to of quite a few immunological ailments is immuno-irritation, which demands specifically made agents. Our differentiated R&D method resulted in one particular of the broadest pipelines in the field, wherever we purposefully match molecules to ailments wherever we believe that they can make the greatest change. Setting up on our a long time-lengthy determination and groundbreaking science, we proceed to progress the regular of care for individuals dwelling with immuno-inflammatory ailments and are performing hand-in-hand with individuals, caregivers and the broader health care neighborhood on healthcare answers for the numerous difficulties of controlling chronic inflammatory ailments, enabling clients to reside their best lives.

Pfizer Inc.: Breakthroughs that Change Patients’ Lives
At Pfizer, we implement science and our international assets to carry therapies to folks that increase and considerably strengthen their life. We attempt to established the typical for high-quality, basic safety, and value in the discovery, development, and manufacture of well being treatment goods, like progressive medications and vaccines. Each and every working day, Pfizer colleagues function across developed and emerging markets to advance wellness, avoidance, remedies, and cures that obstacle the most feared conditions of our time. Consistent with our duty as one particular of the world’s leading ground breaking biopharmaceutical corporations, we collaborate with overall health treatment suppliers, governments, and nearby communities to help and grow entry to trustworthy, economical wellbeing care around the environment. For extra than 170 yrs, we have worked to make a difference for all who count on us. We routinely put up facts that may possibly be vital to investors on our website at www.pfizer.com. In addition, to master a lot more, please stop by us on www.pfizer.com and stick to us on Twitter at @Pfizer and @Pfizer_Information, LinkedIn, YouTube and like us on Facebook at Facebook.com/Pfizer.

DISCLOSURE Recognize: The info contained in this release is as of March 11, 2022. Pfizer assumes no obligation to update forward-seeking statements contained in this release as the end result of new information and facts or upcoming functions or developments.

This release incorporates forward-wanting facts about Pfizer’s acquisition of Arena, Pfizer’s I&I portfolio, like etrasimod, temanogrel and APD418, and envisioned ideal-in-course and development opportunity, like their opportunity gains, that include substantial threats and uncertainties that could cause precise final results to differ materially from all those expressed or implied by these kinds of statements. Hazards and uncertainties involve, amid other issues, hazards related to the ability to recognize the anticipated added benefits of the acquisition, including the likelihood that the predicted benefits from the acquisition will not be realized or will not be recognized within the predicted time period the threat that the enterprises will not be integrated productively destructive effects of the consummation of the acquisition on the market place selling price of Pfizer’s popular inventory and/or working outcomes substantial transaction costs not known liabilities the risk of litigation and/or regulatory steps linked to the acquisition or Arena’s company other company outcomes and uncertainties, together with the consequences of business, sector, enterprise, economic, political or regulatory disorders future trade and interest premiums modifications in tax and other legislation, polices, fees and policies potential enterprise combinations or disposals the uncertainties inherent in exploration and growth, including the means to satisfy expected scientific endpoints, commencement and/or completion dates for clinical trials, regulatory submission dates, regulatory approval dates and/or launch dates, as nicely as the chance of unfavorable new medical knowledge and even more analyses of present clinical knowledge hazards related with interim data the threat that medical demo details are subject to differing interpretations and assessments by regulatory authorities whether or not regulatory authorities will be content with the design and style of and outcomes from the scientific scientific tests whether and when drug applications might be submitted in any jurisdictions for etrasimod, temanogrel, APD418 or any other investigational solutions irrespective of whether and when any such apps could be approved by regulatory authorities, which will count on myriad things, together with creating a perseverance as to whether or not the product’s added benefits outweigh its identified pitfalls and dedication of the product’s efficacy and, if authorised, no matter whether etrasimod, temanogrel, APD418 or any these types of other goods will be commercially effective selections by regulatory authorities impacting labeling, producing processes, security and/or other matters that could influence the availability or business opportunity of etrasimod, temanogrel, APD418 or any this kind of other products and solutions uncertainties with regards to the impact of COVID-19 and competitive developments.

A even more description of hazards and uncertainties can be uncovered in Pfizer’s Yearly Report on Type 10-K for the fiscal year finished December 31, 2021 and in its subsequent reports on Sort 10-Q, which include in the sections thereof captioned “Possibility Aspects” and “Forward-Searching Information and Elements That May possibly Have an impact on Future Outcomes”, as properly as in its subsequent stories on Kind 8-K, all of which are filed with the U.S. Securities and Exchange Fee and accessible at www.sec.gov and www.pfizer.com.

Check out source version on businesswire.com: https://www.businesswire.com/information/property/20220310005794/en/

Contacts

Media Relations:
+1 (212) 733-1226
[email protected]

Investor Relations:
+1 (212) 733-4848
[email protected]